Zobrazeno 1 - 10
of 99
pro vyhledávání: '"E.L. Semikina"'
Publikováno v:
Педиатрическая фармакология, Vol 8, Iss 2, Pp 64-69 (2011)
Identification of the early markers of the onset of atopic march in children remains important for the effective primary and secondary prevention of allergic diseases. The article contains results of the study of the expression of receptors for inter
Externí odkaz:
https://doaj.org/article/4fb3ade7e85e493fbaf4f70119fb5f8c
Autor:
E.I. Alexeeva, S.I. Valieva, T.M. Bzarova, E.L. Semikina, K.B. Isaeva, A.O. Lisitsyn, R.V. Denisova, E.G. Chistyakova, T.V. Sleptsova, E.V. Mitenko
Publikováno v:
Вопросы современной педиатрии, Vol 9, Iss 4, Pp 94-100 (2010)
Treatment of patients with severe clinical course of juvenile rheumatoid arthritis (JRA) is difficult problem. During the last years genetically engineered biological drugs are used equally with traditional immunosuppressive agents in treatment of se
Externí odkaz:
https://doaj.org/article/350270b4b9174488a7c4b4ff642f02b5
Autor:
E.I. Alexeeva, S.I. Valieva, T.M. Bzarova, E.L. Semikina, K.B. Isaeva, A.O. Lisitsin, R.V. Denisova, E.Yu. Gudkova
Publikováno v:
Вопросы современной педиатрии, Vol 8, Iss 5, Pp 19-30 (2009)
The treatment of patients with severe juvenile idiopathic arthritis is difficult problem. The article presents the results of a study of effectiveness and safety of repeated courses of rituximab in 55 patients with different types of juvenile arthrit
Externí odkaz:
https://doaj.org/article/c647374e34394da7bf16f73ec4972433
Autor:
K.B. Isaeva, E.I. Alexeeva, R.V. Denisova, T.M. Bzarova, S.I. Valieva, A.O. Lisitsin, E.Yu. Gudkova, E.L. Semikina, E.A. Kopyl'tsova
Publikováno v:
Вопросы современной педиатрии, Vol 8, Iss 3, Pp 132-138 (2009)
The article gives a case report on patient with severe systemic type of juvenile arthritis, refractory to treatment with classical immuno suppressants and blocker of tumor necrotizing factor Successive application of biological agent — rituximab wa
Externí odkaz:
https://doaj.org/article/b129347041954eaf9372fba9dc9be87c
Autor:
E.I. Alexeeva, K.B. Isaeva, T.M. Bzarova, S.I. Valieva, A.O. Lisitsin, E.L. Semikina, E.A. Kopyl'tsova
Publikováno v:
Вопросы современной педиатрии, Vol 7, Iss 4, Pp 136-142 (2008)
Case report about early debut and severe clinical course of system type of juvenile rheumatoid arthritis, refractory to treatment with classic immunosuppressive agents and blocker of tumor necrosis factor is presented in this article. A successful ap
Externí odkaz:
https://doaj.org/article/866be8d8021d4bed8873ecf4f3cc3b62
Autor:
E.I. Alexeeva, E.L. Semikina, T.M. Bzarova, S.I. Valieva, R.V. Denisova, A.O. Lisitsin, E.Yu. Gudkova, S.S. Akulova, E.A. Kopyl'tsova
Publikováno v:
Вопросы современной педиатрии, Vol 7, Iss 3, Pp 79-85 (2008)
The case of early onset and severe course of systemic juvenile rheumatoid arthritis refractory to classic immunosuppressive agents and blockers of tumor necrosis factor (TNF) is presented in this article. Successful clinical use of biological agent r
Externí odkaz:
https://doaj.org/article/32ded64e52544fc9b7858bacba30c662
Publikováno v:
Вопросы современной педиатрии, Vol 7, Iss 2, Pp 22-29 (2008)
The management of severe juvenile rheumatoid arthritis (JRA) is a complicated problem. The efficacy and safety of Rituximab was investigated in 32 infliximabrefractory patients with different types of JRA, who had failed standard immunosuppressive th
Externí odkaz:
https://doaj.org/article/1df33f12b5b547799a0b13bf5e98422b
Publikováno v:
Вопросы современной педиатрии, Vol 6, Iss 3, Pp 94-100 (2007)
The article describes the clinical case of a difficult systemic juvenile arthritis refractory to traditional immunosuppressant and TNF blocker therapy. The disease was characterized by such extra-articulate manifestations as fever, lymphadenopathy, h
Externí odkaz:
https://doaj.org/article/2aa24a738c214ddc9e05ab2ae5a6e97a
Publikováno v:
Вопросы современной педиатрии, Vol 5, Iss 6, Pp 96-100 (2006)
The article describes the run of the severe systemic juvenile rheumatoid arthritis, which is resistant to the standard antirheumatic therapy. The disease was characterized by such systemic implications of the disease, as: fever, rash, pericarditis, l
Externí odkaz:
https://doaj.org/article/980c86b9f00a4fa196cbc0c6673f6c0b
Autor:
Roman V. Epishev, E.L. Semikina, M A. Leonova, S. G. Makarova, Nikolay N. Murashkin, I. Yu. Pronina, A. P. Fisenko
Publikováno v:
Medical alphabet. :46-50
Congenital epidermolysis bullosa (CEB) is a group of rare genetic diseases of varying severity, which are characterized with the formation of blisters on the skin and/or mucous membranes with minor trauma. In this case, the clinical course of the dis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f7992b7d698dccca03a82a27fc0fd3b6
https://doi.org/10.33667/2078-5631-2021-21-46-50
https://doi.org/10.33667/2078-5631-2021-21-46-50